Kamala Harris’ media whirlwind of the past few days may not move the needle much in the tight race against Donald Trump.

Kamala Harris' media whirlwind of the past few days may not move the needle much in the tight race against Donald Trump. ...

Imuldosa (ustekinumab-srlf) is the fifth ustekinumab biosimilar referencing Stelara to receive regulatory approval in the US.

Growing adoption of animal models in drug development and rising demand for efficient animal models are driving market growth. Based on the numbers obtained from animal model demand analysis, the ...

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a cell surface molecule with immunosuppressive function involved in T-cell immune regulation and proliferation. Researchers from Shanghai Junshi ...

Global study in approximately 180 adults with hidradenitis suppurativa to assess the efficacy and safety of two dose regimens of AVTX-009 ...

Methodology: Eighteen (18) infant rhesus macaques were infected with SHIV and then treated with various combinations of ART, bNAbs, and leronlimab. The study evaluated the efficacy of these treatments ...

On Friday, Italian pharma company Recordati S.p.A agreed to acquire the global rights to Enjaymo (sutimlimab) from Sanofi SA (NASDAQ:SNY) for $825 million as an upfront payment and additional ...

falciparum strains in vitro as well as in a humanized mouse model (the mice were engineered to have human blood). The researchers report in the journal Science this week that MED6-189 works by ...

He labelled Fallon “weak and pathetic” for later apologizing, claiming the moment humanized Trump during the campaign. But Trump saved his harshest words for Kimmel. “I think he said ...